VIR(Vir Biotechnology, Inc.) 的财务报表:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $1.10B | $1.62B | $86.18M | $74.20M | $68.56M |
| 毛利润 | $1.03B | $1.47B | $83.42M | $73.36M | $68.53M |
| 营业利润 | $420.75M | $833.07M | −$684.30M | −$587.16M | −$479.33M |
| 净利润 | $528.58M | $515.84M | −$615.06M | −$521.96M | −$437.99M |
| 经营现金流 | −$47.59M | $1.66B | −$778.78M | −$446.35M | −$391.78M |
| 自由现金流 | −$69.41M | $1.60B | −$800.36M | −$453.65M | −$396.61M |
| 摊薄每股收益 | $3.96 | $3.83 | $-4.59 | $-3.83 | $-3.16 |